Polyamine transporter ATP13A2 and Covid-19: a microarray assay-based and functional analysis study

Authors
1 Department of Biochemistry, Department of Advanced Medical Sciences and Technologies, Jahrom University of Medical Sciences, Jahrom, Iran
2 Department of Biochemistry, Department of Advanced Medical Sciences and Technologies, Research Center for Non-Communicable Diseases, Jahrom University of Medical Sciences, Jahrom, Iran
Abstract
Introduction: Unfortunately, a lot of people infected with and died due to covid-19. The exact mechanism of causative
virus in human body is unknown. The aims of the study were to survey and analysis the microarray data and to perform functional analysis to unveil the new mechanisms of this virus in regarding to human cells.
Materials and Methods: NCBI microarray extracted data were analyzed by GEO2R and R package. Up- and down regulated genes were extracted and functional analysis was performed.
Results: Results showed that in Log2 expression greater than 3 and lesser than -3 of transcriptome, there were 319 and 573 up-regulated genes in mild and severe covid-19 patients, respectively. Also there were 156 and 590 down-regulated genes in mild and severe covid-19 patients, respectively. GO analysis showed that deferentially expressed gene pattern in severe covid-19 patients is related to ATP13A2.
Conclusion: Covid-19 probably regulates its vitality in human cells through interplay with factors such as ATP13A2.
Keywords

World.Health.Organization. WHO Coronavirus(COVID-19)Dashboard2021.Availablefrom:www.covid19.who.int/?gclid=EAIaIQobChMI5ZO7r9rD8gIVkkiRBR3JBgAoEAAYASABEgIDj_D_BwE.2.Berlin DA, Gulick RM, Martinez FJ. Severe covid-19.N Engl J Med. 2020;383(25):2451-60.3.Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.Clinical features of patients infected with 2019 novelcoronavirus in Wuhan, China.Lancet.2020;395(10223):497-506.4.Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al.Clinical characteristics of 138 hospitalized patientswith 2019 novel coronavirus–infected pneumonia inWuhan, China. JAMA. 2020;323(11):1061-9.5.Puelles VG, Lütgehetmann M, Lindenmeyer MT,Sperhake JP, Wong MN, Allweiss L, et al. Multiorganand Renal Tropism of SARS-CoV-2. N Engl J Med.2020;383(6):590-2.6.Ziegler CG, Allon SJ, Nyquist SK, Mbano IM, MiaoVN, Tzouanas CN, et al. SARS-CoV-2 receptor ACE2is an interferon-stimulated gene in human airwayepithelial cells and is detected in specific cell subsets
across tissues. Cell. 2020;181(5):1016-35. e19.7.Saftig P, Klumperman J. Lysosome biogenesis andlysosomal membrane proteins: trafficking meetsfunction. Nat rev Mol cell biol. 2009;10(9):623-35.8.Ghosh S, Dellibovi-Ragheb TA, Kerviel A, Pak E, QiuQ, Fisher M, et al. β-Coronaviruses Use Lysosomesfor Egress Instead of the Biosynthetic SecretoryPathway. Cell. 2020;183(6):1520-35.e14.9.Snijder EJ, Limpens R. A unifying structural andfunctional model of the coronavirus replication
organelle: Tracking down RNA synthesis. PLoSBiol.2020;18(6):e3000715.10.Audano M, Schneider A, Mitro N.Mitochondria,
lysosomes, and dysfunction: their meaning inneurodegeneration. J Neurochem. 2018;147(3):291-309.11.Fleming SMSantiago NA, Mullin EJ, Pamphile S,Karkare S, Lemkuhl A, et al. The effect of manganeseexposure in Atp13a2-deficient mice.Neurotoxicology. 2018;64:256-66.12.Robinson M, Schor S, Barouch-Bentov R, Einav S.Viral journeys on theintracellular highways. Cell MolLife Sci. 2018;75(20):3693-714.13.Spataro R, Kousi M, Farhan SM, Willer JR, Ross JP,
Dion PA, et al. Mutations in ATP13A2 (PARK9) areassociated with an amyotrophic lateral sclerosis-likephenotype, implicating this locus in furtherphenotypic expansion. Hum genomics. 2019;13(1):1-10.14.Usenovic M, Tresse E, Mazzulli JR, Taylor JPKrainc D. Deficiency of ATP13A2 leads to lysosomaldysfunction, α-synuclein accumulation, andneurotoxicity. J Neurosci. 2012;32(12):4240-6.15.Matsui H, Sato F, Sato S, Koike M, Taruno Y, SaikiS, et al. ATP13A2 deficiency induces a decrease incathepsin D activity, fingerprint-like inclusion bodyformation, and selective degeneration ofdopaminergic neurons. FEBS Lett. 2013;587(9):1316-25.16.van Veen S, Martin S, Van den Haute C, Benoy V,Lyons J, Vanhoutte R, et al. ATP13A2 deficiencydisrupts lysosomal polyamine export. Nature.2020;578(7795):419-24.